Published in Eur Respir J on November 01, 1996
Screening for severe obstructive sleep apnea syndrome in hypertensive outpatients. J Clin Hypertens (Greenwich) (2013) 2.65
In-home, self-assembled sleep studies are useful in diagnosing sleep apnea in the elderly. Sleep (2012) 0.98
A portable automated assessment tool for sleep apnea using a combined Holter-oximeter. Sleep (2008) 0.89
Utility of portable monitoring in the diagnosis of obstructive sleep apnea. J Postgrad Med (2015) 0.75
Positional cloning of the Werner's syndrome gene. Science (1996) 10.98
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (1995) 3.74
Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ (1996) 3.08
National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) (2000) 2.95
Origins of health inequalities in a national population sample. Lancet (1997) 2.84
Inequalities in self-rated health: explanations from different stages of life. Lancet (1998) 2.68
Effect of allergen avoidance on development of allergic disorders in infancy. Lancet (1992) 2.45
Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics (2001) 2.23
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol (1999) 2.09
The duration and timing of exposure: effects of socioeconomic environment on adult health. Am J Public Health (1999) 2.03
Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med (1985) 1.99
Dichotomous or categorical response? Analysing self-rated health and lifetime social class. Int J Epidemiol (2000) 1.96
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol Microbiol (1999) 1.95
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Self-rated health and limiting longstanding illness: inter-relationships with morbidity in early adulthood. Int J Epidemiol (2001) 1.82
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Allergen avoidance in infancy and allergy at 4 years of age. Allergy (1996) 1.78
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Structure of tandem RNA recognition motifs from polypyrimidine tract binding protein reveals novel features of the RRM fold. EMBO J (2000) 1.67
Inequalities in self rated health in the 1958 birth cohort: lifetime social circumstances or social mobility? BMJ (1996) 1.66
Using an interactive framework of society and lifecourse to explain self-rated health in early adulthood. Soc Sci Med (2001) 1.65
Social differences in health: life-cycle effects between ages 23 and 33 in the 1958 British birth cohort. Am J Public Health (1997) 1.63
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Predicting persistent disease among children who wheeze during early life. Eur Respir J (2003) 1.54
Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet (1997) 1.52
Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med (2001) 1.51
Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med (1998) 1.48
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol (1997) 1.48
Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli. Nat Struct Biol (1999) 1.46
Child to adult socioeconomic conditions and obesity in a national cohort. Int J Obes Relat Metab Disord (2003) 1.45
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Comparing measures of health inequality. Soc Sci Med (1997) 1.44
Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management. Colorectal Dis (2012) 1.44
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Childhood and adulthood risk factors for socio-economic differentials in psychological distress: evidence from the 1958 British birth cohort. Soc Sci Med (2002) 1.40
Intimin and the host cell--is it bound to end in Tir(s)? Trends Microbiol (2001) 1.40
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immunol (1998) 1.33
Simplified Procedure for the Isolation of Intact Chloroplasts from Chlamydomonas reinhardtii. Plant Physiol (1991) 1.32
Retroviral matrix proteins: a structural perspective. Virology (1998) 1.31
Solution structure and interaction surface of the C-terminal domain from p47: a major p97-cofactor involved in SNARE disassembly. J Mol Biol (2001) 1.30
Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli. EMBO J (2000) 1.27
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol (2000) 1.26
Case report: pulmonary blastoma: presentation of two atypical cases and review of the literature. Br J Radiol (2005) 1.25
Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys (2000) 1.23
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis (2007) 1.18
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). Ann Oncol (2006) 1.17
The prevalence of asthma and wheezing illnesses amongst 10-year-old schoolchildren. Respir Med (2002) 1.16
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Effect of allergen avoidance in infancy on allergic manifestations at age two years. J Allergy Clin Immunol (1994) 1.13
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Characterisation of atopic and non-atopic wheeze in 10 year old children. Thorax (2004) 1.09
Case report: Mucoepidermoid carcinoma in a patient with congenital agenesis of the left upper lobe. Br J Radiol (2003) 1.08
Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10. Thorax (2004) 1.04
Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis (2009) 1.04
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs (2006) 1.03
Trends in eczema in the first 18 years of life: results from the Isle of Wight 1989 birth cohort study. Clin Exp Allergy (2010) 1.03
The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. Clin Exp Allergy (2011) 1.02
Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease. Allergy (2005) 1.01
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
Serum vitamin E concentrations are normal in Friedreich's ataxia. J Neurol Neurosurg Psychiatry (1987) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Site-directed mutagenesis of intimin alpha modulates intimin-mediated tissue tropism and host specificity. Mol Microbiol (2001) 0.99
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Rituximab treatment of mild haemophilia A with inhibitors: a proposed treatment protocol. Haemophilia (2006) 0.98
Trends in cutaneous sensitization in the first 18 years of life: results from the 1989 Isle of Wight birth cohort study. Clin Exp Allergy (2012) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
Eukaryotic RNA polymerase subunit RPB8 is a new relative of the OB family. Nat Struct Biol (1998) 0.93
A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J (1997) 0.92
Dissimilar phorbol ester binding properties of the individual cysteine-rich motifs of protein kinase D. FEBS Lett (1998) 0.92
Association of allergy-related symptoms with sensitisation to common allergens in an adult European population. J Investig Allergol Clin Immunol (2001) 0.92
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Multiple courses of antenatal corticosteroids: a systematic review and meta-analysis. Am J Obstet Gynecol (2001) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J Clin Pharm Ther (2011) 0.91
Cellulose crystallites. Chemistry (2001) 0.90
Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis (1999) 0.90
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma. Eur Respir J (2006) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89